Publication search

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series.

Published in Journal of the neurological sciences

We reported on five people with MS, using immunodepleting disease modifying treatments (anti-CD20 monoclonal antibodies and sphingosine-one-phosphate modulators) and with reduced COVID-19 vaccine response, who had mild-to-moderate symptomatic COVID-19, and were treated with anti-SARS-CoV-2 monoclonal antibodies. In particular, we showed the possibi...

Neurological long-COVID in the outpatient clinic: Two subtypes, two courses.

Published in Journal of the neurological sciences

Symptoms referable to central and peripheral nervous system involvement are often evident both during the acute phase of COVID-19 infection and during long-COVID. In this study, we evaluated a population of patients with prior COVID-19 infection who showed signs and symptoms consistent with neurological long-COVID. We prospectively collected demogr...

Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19.

Published in Journal of the neurological sciences

Persistent cognitive symptoms have been reported following COVID-19 hospitalization. We investigated the relationship between demographics, social determinants of health (SDOH) and cognitive outcomes 6-months after hospitalization for COVID-19. We analyzed 6-month follow-up data collected from a multi-center, prospective study of hospitalized COVID...

The importance of race and other social determinants of health for understanding cognitive health inequality found in Va...

Published in Journal of the neurological sciences

COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series

Published in Journal of the Neurological Sciences

Background and purpose Guillain-Barré-Syndrome (GBS) can follow COVID-19 vaccination, with clinical and paraclinical features still to be precisely assessed. We describe a cohort of patients who developed GBS after vaccination with different types of COVID-19 vaccines. Methods Patients with post-COVID-19 vaccination GBS, admitted to the six hospita...

Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic rev...

Published in Journal of the Neurological Sciences

Introduction One of the rare but potentially serious side effects of COVID-19 vaccination is arterial and venous thrombosis. Acute ischemic stroke (AIS) cases have been reported post COVID-19 vaccination. Herein, we systematically reviewed the reported cases of AIS after COVID-19 vaccination. Method This systematic review was conducted according to...

Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms

Published in Journal of the Neurological Sciences

Objective Neurological symptoms (NS) were often reported in COVID-19 infection. We examined the plasma levels of glial fibrillary acidic protein (GFAP) and S100B together, as brain injury biomarkers, in relation to persistent NS in a cohort of patients with COVID-19 during the acute phase of the disease. Methods A total of 20 healthy controls and 5...

Ischemic stroke shortly after vaccination against SARS-CoV-2: A case-control study.

Published in Journal of the neurological sciences

Vaccination against SARS-CoV-2 has been associated with rare occurrences of severe venous thromboses. Very little data exist about arterial ischemic strokes. We have assessed the features of ischemic strokes occurring shortly after vaccination against SARS-CoV-2 in the Cremona area, Italy. From February 1, to July 31, 2021, all patients with ischem...

Call for correction: Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A met...

Published in Journal of the neurological sciences

Flare of myasthenia gravis induced by COVID-19 vaccines.

Published in Journal of the neurological sciences